Introduction
============

Ventilator-associated pneumonia (VAP) represents 80% of all nosocomial pneumonia. The aim of this study is an epidemiological, performance and outcome evaluation of an ICU, focused in VAP.

Methods
=======

The study was performed in a 13-bed ICU located in São Paulo, Brazil, during 2003. It was a retrospective study, where all consecutive patients admitted were included. All data were collected and analysed in a Brazilian system of performance and quality in the ICU, called QuaTI^®^. Statistical analyses were done, supported by the EpiInfo 2002 software. Clinical characteristics of all patients were presented and then two groups were analysed and compared: VAP group (*n*= 28) and control group (*n*= 231) composed of ventilated patients who did not develop VAP.

Results
=======

From 11 January to 31 December, 483 patients were admitted; 55.69%, were male; median age was 59 years, 362 medical and 121 surgical patients; medium length of stay was 8.91 ± 13.07 days. APACHE II median score was 11.78 ± 7.13; mortality rate was 29.6% and standard mortality rate, calculated by APACHE II, was 1.01. The rate of ventilated patients was 259/483 (53.62%). The VAP incidence was 10.81% and the rate was 10.84 per 1000 ventilator days. The infection agent was identified in 15 patients by bronchoalveolar lavage or blood cultures. The more prevalent were *Pseudomonas aeuriginosa*(6/28), *Klebisiella pneumoniae*(2/28), *Staphylococcus aureus*(2/28).

Conclusions
===========

VAP did not increase mortality but improved ventilated days, ICU length of stay and assistance costs. The APACHE II score was significantly higher in patients who developed VAP. *P. aeuriginosa*was the predominant pathogen.

  Characteristics       VAP (*n*= 28)   Controls (*n*= 231)   *P*value
  --------------------- --------------- --------------------- ----------
  Age (years), median   57              66                    0.10
  \% male               85.7            74                    0.17
  Medical               24              171                   0.17
  Surgical              4               60                    0.17
  ICU stay (days)       30.79 ± 18.06   12.25 ± 14.97         0.000
  Ventilation days      27.61 ± 20.19   10.41 ± 13.21         0.000
  APACHE II score       16.50 ± 5.77    13.96 ± 7.39          0.04
  Death risk (%)        21.39           33.32                 0.02
  Mortality rate (%)    32.14           51.52                 0.053
